Molycorp Playing Russian Roulette Over Interest Payment

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Molycorp Mountain Pass Mine
Molycorp Inc.
Molycorp Inc. (NYSE: MCP) has faced a rough and rocky road over the past four years. Financially speaking, the company is stuck in a deep hole and it seems to be getting pressure from all sides.

The company announced that it will skip a payment of $32.5 million on its 10% Senior Secured Notes due 2020. In fact it is taking advantage of a 30-day grace period that is provided for in an indenture governing the notes.

The company noted that this will not trigger any cross-default provisions in other outstanding debt prior to the end of the grace period and it should not affect current operations.

As previously mentioned, Molycorp has retained financial and legal advisors to assist with the restructuring of its debt. The company plans to use this grace period for the evaluation of different options related to its debt restructuring.

Skipping a payment is generally bad news regardless of the situation, and it appears that shares acted accordingly. Many investors might suggest that this is just another step on the long road down to zero. It’s worth mentioning that this was a $70 stock in 2011, then a $7 stock in 2013, and now less than a $0.70 stock in 2015. If we look ahead another two years, where is this stock going to be?

Molycorp is still facing the issue of being delisted by the NYSE. If this stock doesn’t pick up any forward momentum it will get left in the dust.

In terms of Molycorp’s short interest it declined to 59.5 million shares for its most recent settlement date, May 15. The previous level was a relative high at 61.4 million shares. The highest level in the last 52-weeks was 69.8 million shares in late September 2014.

Shares of Molycorp were down about 19% at $0.43 on Monday afternoon. The stock has a consensus analyst price target of $1.85 and a 52-week trading range of $0.28 to $2.98.

ALSO READ: The 10 Richest Towns in America

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618